FIELD: medicine.
SUBSTANCE: invention relates to medicinal preparations based on iron coordination compounds, namely, to an antiviral agent, which is a system of compounds including an iron coordination compound containing a binuclear form of a dinitrosyl iron complex with glutathione ligands (B-DNIC-GSH) of the formula [(GS-)2Fe2+2(NO)2(NO+)2]2+, and sodium diethyldithiocarbamate (DETC) at a molar ratio of B-DNIC-GSH: DETC=1:1-5. A method of using the said agent is also proposed.
EFFECT: proposed agent has antiviral activity against SARS-CoV-2, as well as the ability to produce nitrosonium cations, and can be used to treat severe forms of viral pneumonia in COVID-19.
7 cl, 3 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETECTING NITROSO-COMPOUNDS AND NITRITE IN BIOLOGICAL OBJECTS | 2008 |
|
RU2395096C2 |
| COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
| SINGLE-NUCLEAR CATIONIC DINITROSYL IRON COMPLEXES, METHOD FOR PRODUCING THEM, NITROGEN MONOXIDE DONOR | 2014 |
|
RU2567245C1 |
| USING DALARGIN FOR PRODUCING AGENTS FOR TREATING COVID-19 CORONAVIRUS INFECTION | 2020 |
|
RU2728939C1 |
| DERIVATIVES OF DI(DIAZONIADISPIRO[5.2.5.2]HEXADECANE)-5-NITROPYRIMIDINE AND THEIR USE FOR TREATMENT OF CORONAVIRUS INFECTIONS, IN PARTICULAR CAUSED BY SARS-COV-2 VIRUS | 2020 |
|
RU2761950C1 |
| AGENT FOR REDUCING RISK AND RELIEVING SYMPTOMS OF BETA-CORONAVIRUS INFECTION | 2021 |
|
RU2747890C1 |
| PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS | 2020 |
|
RU2743593C1 |
| VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743595C1 |
| PEPTIDE IMMUNOGENS AND A VACCINE COMPOSITION AGAINST CORONAVIRUS INFECTION COVID-19 USING PEPTIDE IMMUNOGENS | 2020 |
|
RU2738081C1 |
| PEPTIDE IMMUNOGENS USED AS COMPONENTS OF VACCINE COMPOSITION AGAINST COVID-19 | 2020 |
|
RU2743594C1 |
